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ABSTRACT
Introduction This paper presented qualitative and 
quantitative data collected on the research capacity of 
global health institutions in China and aimed to provide a 
landscaping review of the development of global health as 
a new discipline in the largest emerging economy of the 
world.
Methods Mixed methods were used and they included a 
bibliometric analysis, a standardised survey and indepth 
interviews with top officials of 11 selected global health 
research and educational institutions in mainland China.
Results The bibliometric analysis revealed that each 
institution had its own focus areas, some with a balanced 
focus among chronic illness, infectious disease and 
health systems, while others only focused on one of 
these areas. Interviews of key staff from each institution 
showed common themes: recognition that the current 
research capacity in global health is relatively weak, 
optimism towards the future, as well as an emphasis 
on mutual beneficial networking with other countries. 
Specific obstacles raised and the solutions applied by each 
institution were listed and discussed.
Conclusion Global health institutions in China are 
going through a transition from learning and following 
established protocols to taking a more leading role in 
setting up China’s own footprint in this area. Gaps still 
remain, both in comparison with international institutions, 
as well as between the leading Chinese institutions and 
those that have just started. More investment needs to be 
made, from both public and private domains, to improve 
the overall capacity as well as the mutual learning and 
communication within the academic community in China.
INTRODUCTION
The current COVID-19 outbreak has 
brought the world’s attention to global 
health institutions in China, whose efforts 
on research, public education and policy 
advocacy have a great impact in shaping how 
China can work with the world in tackling the 
biggest threat to face human society today.1 
Universities in China quickly joined the fight 
against COVID-19, first by ensuring the safety 
and continuity of education programmes 
of students at schools, and later by taking 
on their social responsibility and contrib-
uting via biomedical research, public health 
Key questions
What is already known?
 ► Most global health institutions in China were es-
tablished after 2000 and are growing fast in both 
scales and scope of work while still facing many 
challenges.
What are the new findings?
 ► Bibliometric analysis and standardised survey in-
cluded in this study provided detailed quantifiable 
measurements of the research capacity of these in-
stitutions and respective strengths and weaknesses.
 ► Enhancing collaboration with other low- income and 
middle- income countries was a major part of their 
development strategy.
What do the new findings imply?
 ► Research capacity of global health institutions in 
China can be improved to a large extent by increas-
ing collaboration with their international partners as 
well as domestic ones.
 ► Trilateral partnerships can play an important role in 
the development of global health in China.
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interventions, policy making support and public educa-
tion programmes.2–4 On 4 April 2020, Harvard TH Chan 
School and Wuhan University held a joint seminar online, 
in which 13 experts on respiratory diseases, virology, 
epidemiology and health systems from both the USA and 
China shared their experiences on COVID-19 response.5 
Other universities have also organised similar events, 
engaging global health experts from China and other 
high- income countries (HICs) in strengthening interna-
tional dialogue and collaboration towards a united global 
response to this pandemic.6 As the numbers of COVID-19 
cases are now climbing up in Africa, South Asia and Latin 
America, it is critical to also look at how global health 
institutions in China have been conducting research 
and projects working with other low- income and middle- 
income countries (LMICs) and how this could affect 
their ability to take on more global health responsibility 
as one of the two leading economies in the world.
Since the severe acute respiratory syndrome (SARS) 
outbreak in 2003, the Chinese government has become 
more active in participating in global health governance, 
working with various international organisations on 
different health issues.7 This growing global awareness 
trajectory goes beyond the health sector as China seeks 
to establish a more prominent position on the global 
stage. In 2016, Chinese President Xi Jinping announced 
‘Healthy China 2030’, an ambitious agenda to promote 
health across China that also emphasised innovative 
models for strengthening South–South cooperation, 
including ‘The Belt and Road Initiative’ and imple-
mentation of the China- Africa Public Health coopera-
tion plan. Africa makes a special mark in the history of 
China’s global health diplomacy as the earliest health 
outreach project; Chinese medical teams organised by 
the Chinese government to work abroad started in 1963 
when China dispatched its first medical team to Algeria 
in North Africa.
Global health is still a relatively new discipline in 
China. China’s universities started to set up global health 
centres/institutions in 2007, with Peking University being 
the first to establish a global health research centre.8 By 
2014, a few additional universities have set up their global 
health programmes/departments/institutions/centres: 
Fudan, Sun Yat- sen, Central South (Xiangya), Wuhan, 
Kunming, Duke (Kunshan) and Peking Union Medical 
College.9 10 More universities followed suit shortly after 
that. These institutions quickly formed alliances. In 
December 2013, the China Consortium of Universi-
ties for Global Health (CCUGH) was established by 10 
founding universities—Central South University, Chinese 
University of Hong Kong, Duke Kunshan University, 
Fudan University, Kunming University, Peking University, 
Peking Union Medical College, Sun Yat- sen University, 
Wuhan University and Zhejiang University9—embarking 
on an ongoing momentum of global health development 
in China’s academic institutions.8 By the end of 2018, the 
number of CCUGH members grew to 25. In 2015, the 
China Global Health Network was established, involving 
not only academic institutions but also government agen-
cies and actors from the private sector with interest in 
global health. The following year, the Chinese Preventive 
Medicine Association set up its Global Health Branch 
and further consolidated the collective efforts by the 
government and academia in promoting and enhancing 
global health research by China.8
Although institutions whose primary focus is on global 
health did not exist in China until this century, they are 
predated by decades of China’s health collaboration with 
other international players, for most of which China was on 
the receiving end of financial and technical support from 
HICs.11 12 The same trend has been taking place in the 
private sector as well, with China being the top market in 
LMICs for global pharmaceutical companies to set up their 
research and development centres.13 As a result, even today 
most of China’s global health collaboration is with HICs.14 15
China has produced a growing number of publications 
on health that have a global impact. Previous scholars 
have found that China has a higher pharmaceutical 
research publication among the BRICS countries (Brazil, 
Russia, India, China and South Africa)16 and in Asia.17 
Similar studies also recognised China’s leading role 
among the BRICS countries in research and publication 
on HIV,18 tuberculosis19 and other neglected tropical 
diseases.20 Recently, there is also a growing literature on 
the Belt and Road Initiative,21 with a focus on infectious 
disease surveillance since China’s active involvement in 
2014’s Ebola outbreak in West Africa.22 However, other 
scholars think that, although China has been expanding 
its engagement and influence in global institutions, it is 
quite limited in contributing to global public goods.23 
Others discussed that articles published by Chinese 
scholars are more likely to cite other articles published 
within China, which suggests a high level of insularism.19 24
In general, evidence on the research capacity of Chinese 
global health institutions is limited. In a recent paper, Xu 
et al10 noted barriers that Chinese global health institu-
tions face in their work, including lack of and restrictions 
on funding, limited human resource capacity, and lack of 
experience in other LMICs. This article aims to build on 
that effort and makes a unique contribution by collecting 
and analysing first- hand quantitative and qualitative data 
related to research capacity of global health institutions 
in China, and use the findings to depict a more detailed 
landscape of the current academic environment in China 
for the future development of global health.
METHODS
This study consists of three components: a bibliometric 
analysis of global health publications, a standardised survey 
of institutional indicators and qualitative indepth interviews 
of key informants. The bibliometric analysis was conducted 
using the names of 10 universities/organisations, while 
the survey and interviews were conducted on the specific 
departments/institutes of global health at these institutions 
(see online supplemental table 1 for the list).
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The definition of global health has been evolving over 
the past decades, with scholars in this field focusing on 
multidisciplinary collaboration that bridges different 
subject areas such as epidemiology, biostatistics and 
social science, with a focus on interdependence and 
reducing health inequity globally.25 While we recognise 
that global health research includes a wide spectrum 
of studies on health issues across the globe, we applied 
a working definition of global health research based 
on Koplan et al’s description,25 but with two executable 
criteria: (1) the research is conducted in or on LMICs, 
with at least one LMIC other than China involved, using 
the most recent classification of country income groups 
by the World Bank26; and (2) the research is in at least 
one the following areas: (1) maternal and child health 
(MCH), (2) malaria and other infectious diseases (ID), 
(3) disease surveillance, (4) non- communicable diseases 
(NCDs), (5) health system strengthening (HSS), (6) 
environmental health (EH), and (7) international aid, 
development and global governance (AD), as was agreed 
by the author group prior to this study.
Bibliometric analysis
The names of the 10 universities/organisations were 
used in the bibliometric analysis rather than the specific 
global health institutions/departments because (1) most 
of the faculty conducting global health research have a 
primary affiliation with another general department, in 
most cases at a school of public health or school of medi-
cine. Only searching for publications by these global 
health institutions would miss many relevant papers, and 
(2) publications on global health by other scholars in the 
same university are also an indicator of the global health 
research capacity of that institution. The search was 
conducted in three English databases and one Chinese 
database: PubMed, EMBASE, Web of Science (Thomson) 
and WanFang (see online supplemental table 2 for the 
search terms used and online supplemental table 3 for 
the names of institutions used in the search).
Titles and abstracts were reviewed independently to 
select articles on global health topics in the above noted 
seven areas. The addresses/affiliations of all selected 
articles were reviewed to make sure those articles are 
published by those institutions and related to global 
health.
Data extraction was carried out by two researchers 
(XK and YL) independently using a predetermined data 
extraction table with the following categories: study iden-
tifiers (author, year of publication, title) and study char-
acteristics (institution affiliations, language, country/
regions, thematic areas). One article can be categorised 
into one or more of the seven focused areas as used in the 
definition of global health. Five regions of LMICs were 
used: (1) Africa, (2) Asia and Pacific, (3) East Europe, 
(4) Latin America and (5) Middle East. An article will be 
categorised as (6) global if the article involved more than 
one of the five regions of LMICs. Differences between 
the two researchers were resolved with group discussion.
Standardised survey
The survey was designed to understand the workforce, 
programmes, publications and collaborations at global 
health institutes in China. To map the research capacity 
of each institution, we developed a questionnaire that 
contains structural indicators, process indicators and 
outcome indicators. Structural indicators included 
information about researchers and their degrees, back-
grounds and grants. Process indicators investigated the 
training and exchange programmes offered, as well as the 
symposia organised by these institutions. Outcome indi-
cators measured the publications, conference presenta-
tions, postdoctoral training and foreign- based projects 
of each institution. Institutions that agreed to participate 
within the timeline provided were included in both the 
survey and the following indepth interviews. The head 
of that institution was asked to designate an appropriate 
person with the knowledge to fill out the standardised 
survey. Data were summarised by category and by institu-
tions. Descriptive data such as names of sponsoring insti-
tutions were categorised and presented in graphs.
Key informant interviews
Indepth interviews were designed to gather information 
about the barriers faced, experiences gained, support 
needed and academic expectations of global health 
institutions in China. Invitation letters were sent to all 
11 institutions between February and July 2018. All of 
them replied and accepted the interview. The positions 
of each person interviewed were reviewed to make sure 
they have enough knowledge about the institution to 
answer the questions. Each interview lasted 60–90 min, 
where interviewees answered multiple questions on their 
understanding of global health research, institutional 
objectives, barriers, solutions applied so far and external 
support required (see online supplemental table 5 for 
the interview guides used). XK and KT conducted the 
interviews in Chinese, and full transcripts were translated 
to English and sent back to the interviewees for their 
review and approval. Results from the interviews were 
summarised by question and are merged or compared 
for further analysis. Conventional qualitative content 
analysis method was used to analyse the data extracted 
from selected articles.27 Original texts were used to avoid 
biases when recording them. Keywords were extracted 
as they emerged from the text, with no predetermined 
framework, and were then compared with each other to 
collate into a few categories. Themes were summarised 
from those categories as agreed by the research group.
RESULTS
Bibliometric analysis of global health publications
The bibliometric search yielded a total of 21 501 arti-
cles from 10 institutions after duplicates were removed, 
published before 21 August 2018. After the title, abstract 
and full- text review, a total of 1085 articles were included 
in the final analysis (see online supplemental table 4 for 
details).
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The total number of publications on global health 
revealed a clear ‘first tier’ global health institution in 
China: China Center for Disease Control and Preven-
tion (CDC), Peking University and Fudan University 
(see figure 1). This finding was also confirmed in the 
key informants interviewed in later sections. The trends 
showed that the ‘first tier’ group began to emerge from 
the rest of global health institutions in China in 2006 and 
2007 and the gap widened in 2010 and then in 2014 (see 
figure 1).
Institution- specific analysis showed that each global 
health institution had its own distinctive thematic areas. 
For example, global health research at the China CDC 
had a clear focus on ID, which took up more than 68% 
of their total publication records. They also had invested 
quite a few resources on NCDs, with about 20% of publi-
cations. Duke Kunshan University had a focus on NCDs, 
with more than 60% of publications in this area, followed 
by 23% of publications on HSS and 18% on ID. Duke 
Kunshan University was the only institution included 
in this study with more than 50% of publications on 
NCDs. This positioned Duke Kunshan University to be 
a key collaborator on NCD- related projects in Africa 
and other LMICs. Dalian Medical University did not 
yield a big number of publications, but showed a heavy 
focus on HSS (60%) and a good balance among four 
other subjects: MCH (13%), ID (13%), NCDs (7%) and 
AD (13%). Fudan University had almost equal number 
of publications going to ID (26%) and NCDs (24%), 
followed by HSS (17%), MCH (16%), AD (15%) and EH 
(7%). Not surprisingly, more than half of the National 
Health Development Research Center’s (NHDRC) 
publications were on HSS in other LMICs, and another 
36% addressed AD. Note that NHDRC is a government- 
affiliated institution, so a large proportion of their 
research were not turned into publications, but rather 
served as internal reference and policy briefs for govern-
ment departments. Peking University’s leading global 
health area in LMICs was NCDs (37%), followed by MCH 
(20%), HSS (19%), ID (14%) and AD (10%). A small 
percentage (3%) went to EH. Sun Yat- sen University had 
a clear emphasis on disease- specific research, with ID and 
NCDs taking up 41% and 35%, respectively; it was the 
only institution among those selected in this study where 
both ID and NCDs took up more than 30% of the total 
articles. Tsinghua University was unique among others in 
that it had a leading position on EH, especially in relation 
to global warming and global reconciliation mechanisms 
to combat global warming, and generated many publi-
cations on global governance. As a result, both EH and 
AD took up 27% of the total articles, followed by ID at 
24% and HSS at 20%. Tsinghua University’s advantage 
in science and technology put them in a unique posi-
tion to continue leading the area of EH and other global 
health efforts in fighting against the negative health 
impacts brought by climate change. Wuhan University 
had a similar subject breakdown compared with Peking 
University: NCDs took up the leading position (36%) 
and ID took up a smaller proportion (18%), while HSS 
and MCH each took up around 20%. More global health 
articles published by teams at Xi’an Jiao Tong University 
were on ID (39%) and MCH (31%) than NCDs (22%); 
HSS took up another 14% (see table 1 for more details).
Geographically speaking, there was much less vari-
ance among these global health institutions. Global 
health research that involved more than two low- income 
and middle- income continents took the most part of all 
publications. It is also worth noting that in most of these 
cross- continental collaboration research projects, such as 
the Global Burden of Diseases Studies, SAGE (Study on 
Global Ageing and Adult Health), International Union 
Against Tuberculosis and Lung Disease, Global Project 
on Anti- Tuberculosis Drug Resistance Surveillance, and 
WHO- recognised national influenza centres, scholars 
from Chinese institutions played more supporting roles 
than leading roles. Very few of those publications listed 
scholars from Chinese institutions as first or corre-
sponding authors.
For articles where only one low- income and middle- 
income continent was involved, Asia ranked the highest 
in terms of articles, followed by Africa, with very minimal 
publications for other continents: Latin America, Middle 
East and East Europe. This pattern was almost identical 
across all institutions, with very slight differences.
Standardised survey
Nine out of eleven standardised surveys were completed, 
and two of nine only had partial data due to time availa-
bility issues of faculty members. Only data that were later 
validated by the study group were selected for presenta-
tion. For example, self- reported number of global health 
publications was dropped from the table, since each insti-
tution might have used a different definition of global 
health when counting publications.
Although ‘global health institutes or departments’ 
were established, the number of full- time professors at all 
surveyed institutions was limited (see tables 2–3). Not all 
Figure 1 Number of publications on global health from 10 
institutions in China. CDC, China Center for Disease Control 
and Prevention; DKU, Duke Kunshan University; DMU, 
Dalian Medical University; FU, Fudan University; NHDRC, 
National Health Development Research Center; PKU, Peking 
University; SYSU, Sun Yat- sen University; THU, Tsinghua 
University; WU, Wuhan University; XJTU, Xi’an Jiao Tong 
University.
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schools offered courses on global health for undergradu-
ates and graduates. Even within schools that had courses, 
most of them were introductory courses, revealing limited 
capacity in global health teaching.
In general, the number of grants received for global 
health has been increasing for all nine institutions 
surveyed. Although the amount of grants fluctuated over 
the years, the overall trend indicated an upward trajec-
tory. Besides Peking University and Fudan University, 
Xi’an University and Sun Yat- sen University also received 
comparable amounts of funding for global health. In 
terms of sources of funding, international sponsors played 
an indispensable role; all surveyed institutions had at 
least one sponsor outside of China. The biggest sponsor 
was the UK government through the Department For 
International Development. The funders of those grants 
generally fell into three categories: (1) Chinese govern-
ment and its affiliated organisations, (2) foreign govern-
ment and their affiliated organisations, and (3) civil 
society organisations. Each category included a variety 
of players, some of which have supported more global 
health programmes in China than others (see figure 2).
Some schools prioritised organising short- term training 
courses or holding symposia to teaching curriculum 
to full- time students (eg, Fudan offered 23 short- term 
training courses and 0 curriculum for students during 
Table 2 Research and education resources from selected global health institutions in China
Faculty (n)
By degree
M D F G (2006–2017) C- SF C- S T- D T- I IRB
CDC- NIPD 12 0 12 0 24 NA NA 8 6 NA
DKU 10 0 10 5 22 9 NA 2 0 NA
DMU 5 0 0 0 1 8 0 0 0 0
FDU- N 11 5 6 0 2 0 0 0 0 1
FDU- PH 4 0 1 0 7 0 0 23 0 1
PKU 9 1 8 0 15 5 4 3 0 1
SYSU 13 0 14 2 3 2 NA 1 0 1
XJTU 9 1 8 0 17 5 0 0 0 0
THU 2 0 2 0 4 8 0 20 0 0
C- SF: number of curriculum on global health offered to undergraduate and postgraduate students during spring/fall semester; C- S: number 
of curriculum on global health offered to undergraduate and postgraduate students during summer semester; T- D: number of training on 
global health offered to domestic executives or officials; T- I: number of training on global health offered to international executives or officials; 
IRB: is IRB set up to review relevant studies? (1=yes, 0=no).
CDC- NIPD, China Center for Disease Control and Prevention, National Institute of Parasitic Diseases; D, doctor’s degree or above; DKU, 
Duke Kunshan University; DMU, Dalian Medical University; F, foreign researchers; FDU- N, Fudan University School of Nursing; FDU- PH, 
Fudan University School of Public Health; G, grants received on global health; IRB, Institutional Review Board; M, master's or above; NA, not 
applicable; PKU, Peking University; SYSU, Sun Yat- sen University; THU, Tsinghua University; XJTU, Xi’an Jiao Tong University.
Table 3 Research and education outcomes from selected global health institutions in China
SE S P PG: 2006–2017 PD: 2006–2017 African partners DC
CDC- NIPD 4 13 NA NA 18 7 1
DKU NA 5 NA NA 8 4 1
DMU 1 5 6 3 1 0 1
FDU- N 0 1 1 0 0 0 0
FDU- PH 0 9 0 0 0 0 0
PKU 1 2 0 1 0 3 0
SYSU 7 5 3 11 0 1 1
XJTU 2 2 6 78 7 0 0
THU 1 1 0 77 0 2 0
SE: number of scholar exchange programmes with other low- income and middle- income countries; S: number of symposia organised in 
global health; P: number of conference presentations in global health; PG: number of postgraduate students trained in global health; PD: 
number of postdoctoral fellows trained in global health; DC: domestic collaboration: are you collaborating with another global health institute 
in China on global health projects? (1=yes, 0=no).
CDC- NIPD, China Center for Disease Control and Prevention, National Institute of Parasitic Diseases; DKU, Duke Kunshan University; 
DMU, Dalian Medical University; FD- PH, Fudan University School of Public Health; FU- N, Fudan University School of Nursing; PKU, Peking 
University; SYSU, Sun Yat- sen University; THU, Tsinghua University; XJTU, Xi’an Jiao Tong University.
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the surveyed time), which showed the different devel-
opment strategies in the surveyed institutions. Others 
such as Dalian Medical University organized periodic 
extra- curricular seminars on global health that was not 
included this table. All nine institutions had interna-
tional partners in global health, including multilateral 
organisations such as WHO. A few institutions such as 
Peking University and Sun Yat- sen University listed part-
nering institutions in Africa. However, the number of 
their African partners was dwarfed by that of global part-
ners in other regions (see table 3 for more details).
Key informant interviews
When asked about their understanding of global 
health research, representatives from all 11 institutions 
mentioned key features such as ‘cross border’, ‘collab-
oration’ and ‘multi- disciplinary’. In addition, a few key 
common features of the China- Africa health collabo-
ration were recognised by the majority of interviewees, 
including (1) a historical friendship that goes beyond 
the health sector, (2) long history of China- Africa health 
collaborations, (3) current high level of political will, (4) 
featuring the application of China’s success and experi-
ence in health development to Africa together with inter-
national organisations, and (5) a foundation of mutual 
benefits.
Besides Africa, there hasn’t been another continent in the 
world, to which China has systematically and consecutively 
sent medical teams.
Before, we used to stress the word “cooperation”, which 
means each side comes with their own interests and make 
the transaction; now we stress the word “collaboration”, 
which emphasize on shared value and shared goals. China- 
Africa Health Collaboration should be based on this spirit.
Among these key common features, many interviewees 
emphasised the unique position of Africa in their global 
health outreach strategies, as illustrated by the quotes 
above.
Most institutions had comprehensive goals for their 
global health capacity, including promoting health, 
research/knowledge generation, education and training, 
technical support and consultation, and policy support 
for the Chinese government, while some institutions had 
priorities of one or two over the others. For example, the 
Global Health Institute at Wuhan University indicated a 
strategic focus on human resource training (see online 
supplemental table 6 for more details).
Barriers faced collectively by all institutions to 
conducting global health research, especially in rela-
tion to LMICs and Africa specifically, were identified 
and described in detail below. Experiences shared to 
overcome each barrier are listed as well. No institution 
claimed that they have overcome all barriers to an extent 
they are satisfied with. Rather, many interviewed said 
that, for some of the barriers, they have not come up with 
any solutions at all (see box 1 for the direct quotes from 
the indepth interviews). The barriers noted included the 
following:
1. Lack of policy and political support: No clear guidance 
on global health diplomacy for China, so researchers 
in this field felt that they did not have a clear under-
standing, especially for institutions directly affiliated 
with the Chinese government. In addition, China’s 
National Health Commission had relatively weaker 
political power within the government system, which 
made it difficult to convince and mobilise other non- 
health sectors to support decision making and proj-
ect implementation in health. It was noted that global 
health research and projects involved cross- border 
Figure 2 Sources of funding for global health institutions in China.
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activities, and almost all Chinese universities, with very 
few exceptions, were public universities, which meant 
that international trips had to be approved by the gov-
ernment before taking place.
2. Lack of partners/networks in LMICs: Many institu-
tions stressed the importance of having a close and 
day- to- day partner for their research project in LMICs. 
Without a local partner, it was difficult to conduct 
population- level interventions that required a much 
deeper understanding of the community. Also, they 
noted that it was crucial to develop appropriate tech-
nologies with a local partner, who had detailed knowl-
edge of the context, including applicable technolo-
gies, regulations of medicine and medical devices, 
functions of delivery platforms, etc. Due to lack of un-
derstanding of other countries, it was difficult for Chi-
nese global health institutions to identify good part-
ners to start with. Even when they did, their partners 
usually suffered from lack of resources, which highly 
restricted their capability in the collaboration.
3. Lack of knowledge on local context, language and 
culture: Even with a good local partner, one needed 
to have a decent understanding of the local context 
and culture in order to design and implement global 
health research. Local context included but was not 
limited to how people interpret medical terms, how 
each level of healthcare system functioned, how med-
ical products and practices were regulated, and the 
specific epidemiological and demographic profile of 
the local population. In addition, China had a well- 
functioning data collection system following the SARS 
outbreak on IDs and beyond, which most other LMICs 
did not have. So it was difficult to expect things would 
happen as they did domestically. Most interviewees 
compared their experience in other Asian countries 
with that in Africa and emphasised the higher sense 
of distance between the cultures of China and Africa, 
compared with that in other Asian countries. In ad-
dition, not having adequate knowledge of the local 
legal, political and academic structures also exacerbat-
ed the barriers to identifying and establishing a good 
partner/network in those LMICs. It also generated 
safety concerns for researchers conducting research 
on the ground.
4. Lack of experienced faculty and trained students/re-
searchers: Many faculties in those global health insti-
tutions had education and/or training background in 
HICs, but not in other LMICs. Many of them did not 
have any experience conducting research in another 
LMIC. Not many universities in China provided sys-
tematic training on global health for undergraduate 
or postgraduate students.
5. Funding limitations: Interviewees highlighted limited 
funding sources for global health research in China, 
with the exception of the UK- China Global Health 
Support Program, to which Peking University and 
Fudan University were the two main recipient institu-
tions. The current South–South Collaboration Fund 
did not have funding that targeted global health, nor 
were there other major national funds, such as the Na-
tional Natural Science Foundation of China, the Na-
tional Social Science Fund of China, Major Technol-
ogy Programme Fund, etc. Also, even if these institu-
tions were given funding to do global health research, 
these funds had limitations on overseas expenses, 
which largely restricted research planning and imple-
mentation. Currency exchange was also a challenge, 
since renminbi to US dollar exchange was highly reg-
ulated in China and funding in renminbi can only be 
used abroad after being converted to US dollars.
6. Inappropriate credit system for young faculty: Many 
interviewees mentioned that the current credit system 
in Chinese universities was not favourable to faculty 
doing global health research in another LMIC. For 
example, if a young faculty spent about a year in an 
Box 1 Quotes from indepth interviews: barriers to global 
health research
 ► “China has years of experience of sending medical teams to Africa, 
and on how Chinese people working abroad. So, you have policy 
guidance on how to arrange people and projects. But for public 
health, we don’t have any policy guidance. When we explore those 
collaborations, we need to bring our experiences back to policy 
makers in China, to help them make relevant policies in the future.”
 ► “We want to find suitable partner and to establish cooperative rela-
tionship with some African countries. But now we haven’t. We need 
more data and information for African countries.”
 ► “Also, the culture of Africa is difference from ours. When we visit 
South East Asian countries, we feel we share a lot of things with 
them, so we can easily understand what and how people think. But 
it’s different in Africa. And Africa is not just one country but a variety 
of different countries with different background.”
 ► “Our team is almost 100% educated in Europe and North America. 
They are very familiar with developed countries, but only macro- 
level understanding of societies, economies and health issues in 
developing countries. They lack the experience of doing on- the- 
ground work in those settings.”
 ► “There is little funding opportunity from within China to fund re-
search abroad. Very rarely do global health institutions from China 
conduct research abroad. So far, DFID is the biggest sponsor in 
this area, and the funds mainly went to PKU and Fudan. But still, 
the DFID funds were essentially for service delivery, not research- 
oriented, which is very rare, and not available within the National 
Science Funds of China.”
 ► “In the current evaluation system in universities, the criteria for 
promotion are mostly number of publications, teaching workload, 
number of funds etc. And that poses a great challenge to global 
health research. We need to go to another country and truly help 
local people, to be able to do global health research, not to remotely 
control from China. They’d better stay there for one or two years. 
But, with the current evaluation and promotion system, it’s difficult. 
If they choose to go to a developed country for one or two years, it 
will be considered advanced training, and it adds points to his or 
her evaluation, but if they choose to go to Africa, it will not only add 
points but deduct points, because it will affects his or her teaching 
work and number of publications. We face barriers in encouraging 
young faculty to do global health research.”
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institution in an HIC, that experience would be count-
ed as ‘advanced training’, which added to the profile 
for future promotion considerations. However, if he/
she spent that year in another LMIC, it would not 
count.
Different solutions that tackle each of the barriers 
presented above are listed in table 4; they were used 
by the interviewed institutions to overcome barriers, 
although these were noted to be inadequate to resolve 
the concerns.
Each institute also listed ways external support could 
be provided to strengthen their capacity in global health 
research. Interviewees mentioned different stakeholders, 
which we summarise in table 5.
Common features were also identified about their 
expectations of research capacity in global health in 
the next 5–10 years. In addition to a strong will to 
improve the overall research capacity, most interviewees 
were very optimistic about the development of overall 
research capacity that would enable them to grow out 
of the current ‘infant phase’. Many emphasised that 
they expected to grow their impact and establish closer 
ties with other LMICs, especially Africa, and expand 
on existing networks or establishing more cross- region 
academic networks within the next decade (see online 
supplemental table 7 for details).
DISCUSSION
This study confirmed previous research that global 
health institutions in China are in their early develop-
ment and are facing many barriers.28 Our bibliometric 
analysis showed that, before 2004, none of those institu-
tions had a sizeable publication record on global health, 
which corresponds to previous scholars’ observation on 
how Severe Acute Respiratory Syndrome (SARS) had 
played an important role in sparking China’s engage-
ment in global health.7 The number of full- time profes-
sors at all surveyed institutions was limited, which shows 
both the need to prioritise global health in universi-
ties and the deficiency of global health workforce. Our 
study also confirmed the huge variance in development 
among these domestic global health players, as has been 
published by other scholars before in other health- 
related fields.28 Both the different focus and an internal 
gap suggest the potential of fostering collective growth 
by learning from each other. Institutions not included in 
this study could also use this report as a reference to posi-
tion themselves.
To this date, the Natural Science Foundation of China 
has not released global health- focused research funds 
despite strong and long- standing advocacy for that from 
universities and research institutions. Results from our 
standardised survey showed that most of the funding for 
global health comes from bilateral agencies or private 
international foundations, rather than domestic agen-
cies, public or private, which is corroborated by findings 
from earlier research.10 As the Chinese government is 
Table 4 List of barriers and solutions for global health 
research at Chinese institutions
Barriers
Solutions taken by global health institutions 
in China
Lack of policy 
and political 
support
Visit the local Chinese embassy before you start 
your project.
Mobilise other ministries within the Chinese 
government by inviting them to meetings and 
explaining how global health research can help 
the development of their respective sectors.
Use one’s own network within the political 
system to make things happen, although the 
impact might be small.
Have higher level agreement signed (at 
ministerial level) before you start your project.
Lack of partners 
in LMICs
Start from simple, descriptive and small- 
scale projects and gradually move on to more 
complicated research.
Send team from China to work together with 
local partners.
Collaborate with partners from HICs.
Ask bilateral agencies from HICs or multilateral 
agencies that have experience working in those 
LMICs to recommend partners.
Build strong relationship with our existing 






Make use of overseas students in the campus.
Recruit faculty member from other LMICs.
Get trained by other schools or department 
with knowledge of the local community, such as 
social scientists and anthropologists of African 
culture and religion.
Collaborate with partners from HICs.
Make more friends through collaborations.
Get trained by the local Chinese embassy 




Recruit faculty from other LMICs.
Recruit faculty with experiences in LMICs.
Start from simple, descriptive and small- 
scale projects and gradually move on to more 
complicated research.
Collaborate with partners from HICs.
Organise lectures, symposia and conferences 
to attract more young students and scholars 
joining global health.
Provide internal training to staff members.
Funding 
limitations
Fund- raise from within the university.
Fund- raise from both public and private sectors.
Work together with the school’s management 
department to think of creative ways to use the 
fund.
Collaborate with partners from HICs, such as 
the UK, USA and the Netherlands.
Inappropriate 
credit system for 
young faculty
Build a strong team with strong team spirit.
Support those faculty with their publications.
HICs, high- income countries; LMICs, low- income and middle- 
income countries.
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investing more in its global strategy, more resources 
need to be appropriated to the health sector to provide 
a balance to the economic- driven approach that has 
attracted heavy criticism. In addition to more diverse 
funding sources, the results from this article also indicate 
a growing need for the Chinese government to set up 
clearer guidelines on global health strategies and estab-
lish proper non- capital incentives such as career advance-
ment for researchers and educators working on global 
health to expand their impact to other LMICs.
Global health institutions in China are at different 
stages of development, and this study showed that there 
are early signs of strength area for each institution: some 
have a balanced investment in different thematic areas, 
while others have clear focus of research and practice 
in one or two of them. For example, NHDRC’s strength 
is on HSS, China CDC on ID and Tsinghua University 
on EH. Peking University and Fudan University both 
have a balanced record across different subject areas, 
with Peking University having a slight edge in NCDs and 
Fudan University in ID. This information will help guide 
future policy making and strategising, both for indi-
vidual institutions as well as for the country. We highly 
recommend strategic partnering among domestic global 
health institutions which could immediately expand the 
portfolio of what kind of research can be conducted and 
the quality of those research or outreach global health 
projects to other LMICs. Some of the recent publications 
already showed this trend.29
Most of the publications yielded in this study involved 
multiple continents where the Chinese institutions serve 
as one of the partners for data collection. More detailed 
analysis needs to be done on the database to get more 
insights on what roles Chinese institutions played in 
these cross- continental global health collaborations. 
These publications were followed by some publications 
with partners in Asia, a smaller number of publications 
in Africa, and a minimal amount of publications in other 
areas such as Latin America and the Middle East. We thus 
suggest that global health institutions in China make use 
of the experiences they have accumulated in HICs and 
other Asian countries when they seek expansion of their 
global partners to Africa and the rest of the world. As 
shown by the results from the interviews, this is also a 
strategy that global health institutions in China are very 
willing and are actively seeking to adopt: to improve their 
capacity to generate global public goods and to commu-
nicate with other LMICs better by strengthening the 
existing partnerships with and continuing to learn from 
those institutions in HICs.
In 2015, the Chinese government announced that they 
are joining hands with the US government in providing 
technical support to African Union for building an Africa 
Centres for Disease Control and Prevention.30 This 
example showed the resolve from both China and the 
USA to be responsible great powers on the global stage 
that we continue to need today, if not more, in the face 
of COVID-19, the greatest danger to globalisation human 
beings have ever encountered. As the tension between 
the developed world led by USA and China continues 
to rise in a global economic and public health crisis, 
and the spirit of competition seems to have triumphed 
over the spirit of cooperation, global health institutions 
on multiple sides can play a role to bridge the gap in a 
trilateral way. We propose that multilateral collaborations 
could take the form of collaborative research, multichan-
nelled sponsorship, as well as training programmes that 
rotate across different institutions, as was suggested by 
multiple participants during the interviews.
Last but not least, our findings showed a shared interest 
across all global health institutions in China to establish and 
strengthen research collaborations with partners in Africa 
in the context of a long history of friendship between the 
two sides. While the history of a strong health collaboration 





To provide more funding in global health.
To provide more logistical support for projects 
running abroad.
To more closely integrate health into other 
foreign aid programmes of the Chinese 
government.
To have clear national strategies and policy 





To provide more funding in global health.
To build capacity to assist research institutions 
in implementing global health projects in other 
LMICs (for Chinese organisations).
To have more staff exchange programmes 
with the Chinese government and other 
organisations.
To recognise and promote the efforts and 





To organise training on:
 ► How to apply for global health funds, how to 
collaborate with local teams, etc.
 ► Intercommunication skills and cultural issues.
 ► Basic global health concepts.
 ► Epidemiological and health systems of 
LMICs.
To organise short- term similar/workshops.
To have exchange scholar programmes.
To collaborate on global health projects: apply 
for funds together, design the study together and 
write report/articles together.
To organise trilateral partners, sharing resources, 
networks, channels and experiences with China, 
while also learning from how Chinese conduct 
global health research/programmes.
To recognise and promote the efforts and 
progress made by China’s global health 
institutions.
To form closer and long- term research partners.
LMICs, low- income and middle- income countries.
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between China and Africa has been well documented,31 
recent news of increased tension between Chinese commu-
nities in Africa and Africans,32 as well as African commu-
nities in China and Chinese,33 have brought concerns to 
continuing the traditional friendship in modern days and 
indicated a fissure that needs to be addressed in order not 
to hamper future links. On the other hand, as many global 
health institutes in China are actively seeking collabora-
tors in Africa, this study also provides valuable information 
to global health institutes in Africa to strategise on which 
Chinese institutes to collaborate with and in what areas, for 
mutually beneficial outcomes.
Many established global health organisations are 
reflecting on the element of supremacy in the practice of 
global health in modern days, and calls for ‘the decoloniza-
tion of global health’.34 This ongoing movement continues 
to emphasise that global health is built on the basis of equity 
and justice, a principle China states it has been following in 
dealing with other LMICs since the Mao’s era and has reiter-
ated through the promotion of South–South collaborations 
and the Belt and Road Initiative.35 Chinese officials draw 
attention to China’s own experience as being colonised 
and as the recipient of multiple global health aid projects 
in the past century. All partners engaged in global health, 
including those in China and other HIC settings, need to be 
cognizant of the legacy of colonisation and work as partners 
in a way that advances shared learning and form a global 
health solidarity that is truly based on equal footing of all 
stakeholders.
This study has a few limitations. First, new global health 
institutions continue to emerge in China in recent years, 
including between the completion of our study and the 
publication of this paper, such as the Global Health Center 
at China’s CDC, and School of Global Health cosponsored 
by Shanghai Jiao Tong University School of Medicine and 
Chinese Center for Tropical Diseases Research. As a result, 
although we have included the input of key players in global 
health research in China at the time, whether the informa-
tion depicted in this paper is exhaustive warrants further 
investigation in future research. In addition, only data 
from global health institutions in China were collected and 
most data were qualitative; thus, the results only showed a 
limited picture of the ‘gaps’, both within those institutions 
and with their counterparts outside of China, especially in 
HICs. For example, if information on funding size was also 
collected, we would be able to generate ‘funding to impact’ 
ratio and compare across institutions. Our limited scope of 
definition of global health also ruled out a large number 
of publications on China’s domestic health issues or those 
on the health issues in HICs. We hope this study can pave 
the foundation for more future research on global health 
institutions in China, Africa and other countries that would 
ultimately foster more effective and efficient global health 
collaborations.
Global health development involves not only academic 
and research institutions, but also a wide variety of public, 
private and civil society organisations, many of which 
are emerging in China in recent years. With the newly 
established China Agency on International Development 
and Collaboration, as well as an increasing number of 
Chinese entities going to Africa or other LMICs, led by or 
influenced by the Belt and Road Initiative, more research 
is needed to better understand the landscape in which the 
plethora of players have huge potential health and social 
impacts.
Growing opportunities await global health in China, as 
China seeks to play a more significant role on the inter-
national stage, transitioning from mainly a recipient of 
funding and technical support from other HICs to a 
global leader and resource provider. Trilateral platforms 
that use both China’s past collaboration with institutions 
in HICs as well as the existing bilateral and multilateral 
networks led by those institutions have a unique place 
in this landscape. The China- Harvard- Africa Network was 
established as such an example for knowledge sharing, 
capacity building and finding solutions to improve health 
system performance in both China and Africa.36 This 
paper serves towards that purpose as we continue to work 
on pursuing further understanding of global health insti-
tutions in China and Africa to foster stronger partners.
Patient and public involvement statement
Patients or the public were not involved in the design or 
conduct of our research, but we plan to involve the public 
and related stakeholders in the further reporting and 
dissemination of our research. Full report of our research 
has been shared with Bill and Melinda Gates Foundation 
and needs to abide by their respective policies. Key findings 
from this research will be shared on the website of Harvard 
TH Chan School of Public Health, and we will actively reach 
out to institutions to which our research can be beneficial.
Author affiliations
1Global Health and Population, Harvard University T H Chan School of Public Health, 
Boston, Massachusetts, USA
2Global Health Research and Consulting, Yaozhi, Yangzhou, China
3Vanke School of Public Health, Tsinghua University, Beijing, China
4Department of Hospital Management, Fudan University, Shanghai, China
5School of Public Health, Sun Yat- sen University, Guangzhou, China
6Sun Yat- sen Global Health Institute, Sun Yat- sen University Institute of State 
Governance, Guangzhou, Guangdong, China
7School of Health Sciences, Wuhan University, Wuhan, China
8Global Health Research Center, Dalian Medical University, Dalian, China
9China National Health Development Research Center, Beijing, China
10Global Health Institute and School of Public Health, Xi'an Jiao Tong University, 
Xi'an, China
11Global Health Research Center, Duke Kunshan University, Kunshan, China
12SMU Institute for Global Health and School of Health Management, Southern 
Medical University, Guangzhou, Guangdong, China
13Fudan University School of Nursing, Shanghai, China
14National Institute of Parasitic Diseases, China CDC, Shanghai, China
15School of Global Health, Shanghai Jiao Tong University School of Medicine & 
Chinese Center for Tropical Diseases Research, Shanghai, China
16Harvard University T H Chan School of Public Health, Boston, Massachusetts, USA
17Department of Public Health and Primary Care, University of Cambridge, 
Cambridge, UK
18Department of Global Health, School of Public Health, Peking University, Beijing, 
China
19Institute for Global Health and Development, Peking University, Beijing, China
20Tencent Healthcare, Tencent, Shenzhen, Guangdong, China
21Addis Continental Institute of Public Health, Addis Ababa, Ethiopia
12 Kwete X, et al. BMJ Global Health 2021;6:e005607. doi:10.1136/bmjgh-2021-005607
BMJ Global Health
Contributors All authors conceived the research idea during group meetings. XK 
and KT developed the research protocol under the supervision of YB, WF and ZZ. 
XK, YL and RY conducted the literature search and collected standardised survey 
questionnaires with support from KT, CF, YC, ZM, RR, YuW, YoW, CW, DX, YZ, XZ, XL, 
CH and YG. XK and KT conducted the interviews. XK, YL, RY and KT completed the 
data analysis. XK made the first draft of the manuscript. All authors reviewed and 
approved the manuscript.
Funding This study was funded by the Bill and Melinda Gates Foundation Beijing 
Office (award number: OPP1175963; fund number: 263682).
Competing interests None declared.
Patient consent for publication Not required.
Ethics approval This study was reviewed and approved by the Office of Human 
Research Administration at Harvard TH Chan School of Public Health, as well as the 
Institutional Review Board of Peking University Health Science Center.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement Data from the literature analysis and further 
de- identified data from the interviews are available upon request. Please email  
xij029@ mail. harvard. edu if you need access to more data used in this article.
Supplemental material This content has been supplied by the author(s). It has 
not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been 
peer- reviewed. Any opinions or recommendations discussed are solely those 
of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and 
responsibility arising from any reliance placed on the content. Where the content 
includes any translated material, BMJ does not warrant the accuracy and reliability 
of the translations (including but not limited to local regulations, clinical guidelines, 
terminology, drug names and drug dosages), and is not responsible for any error 
and/or omissions arising from translation and adaptation or otherwise.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits 
others to copy, redistribute, remix, transform and build upon this work for any 
purpose, provided the original work is properly cited, a link to the licence is given, 
and indication of whether changes were made. See: https:// creativecommons. org/ 
licenses/ by/ 4. 0/.
ORCID iDs
Xiaoxiao Kwete http:// orcid. org/ 0000- 0003- 1535- 1068
Yingyao Chen http:// orcid. org/ 0000- 0002- 3470- 0748
Dong (Roman) Xu http:// orcid. org/ 0000- 0001- 7438- 632X
REFERENCES
 1 Bedford J, Enria D, Giesecke J, et al. COVID-19: towards controlling 
of a pandemic. Lancet 2020;395:1015–8.
 2 Qiu Y. Universities combat COVID-19: response and responsibility, 
2020. Available: https:// news. cgtn. com/ news/ 2020- 03- 28/ 
Universities- combat- COVID- 19- Response- and- responsibility- 
Pe7JH8lpf2/ index. html [Accessed 25 May 2020].
 3 Zhuang P. ‘Strong immune response’: Chinese Covid-19 vaccine 
team reports promising results, 2020. Available: https://www. scmp. 
com/ news/ china/ science/ article/ 3085502/ strong- immune- response- 
chinese- covid- 19- vaccine- team- reports [Accessed 25 May 2020].
 4 Huang Y. On PKU providing policy recommendations to China’s 
central government on COVID-19, 2020.
 5 Health HCSoP. Strengthening system response to epidemic 
outbreak: lessons from COVID-19. Harvard th Chan School- Wuhan 
university joint seminar on health system response to COVID-19: 
Harvard Chan school of public health 2020.
 6 Seminar on Global Health Governance amid COVID-19 held at 
Peking University, 2020. Available: http:// newsen. pku. edu. cn/ news_ 
events/ news/ global/ 9762. htm [Accessed May 25th 2020].
 7 Chan L- H, Chen L, Xu J. China's engagement with global health 
diplomacy: was SARS a watershed? PLoS Med 2010;7:e1000266.
 8 Guo Y. Development of global health research in China. J Glob 
Health 2017;7:020102.
 9 Liu P, Guo Y, Qian X, et al. China’s distinctive engagement in global 
health. The Lancet 2014;384:793–804.
 10 Xu DR, Cheng F, Chen Y, et al. Harnessing China's universities for 
global health. Lancet 2016;388:1860–2.
 11 Rawson RA, Woody G, Kresina TF, et al. The globalization of 
addiction research: capacity- building mechanisms and selected 
examples. Harv Rev Psychiatry 2015;23:147–56.
 12 Kilmarx P, Livinski A. International research funded by the US 
National Institutes of health (NIH): a bibliometric analysis of 
publications with NIH funding and Non- US authors – 2014. Annals of 
Global Health 2017;83:110.
 13 Ni J, Zhao J, Ung COL, JY N, COL U, et al. Obstacles and 
opportunities in Chinese pharmaceutical innovation. Global Health 
2017;13:21.
 14 Zhou L, Li Y, Bosworth HB, et al. Challenges facing translational 
research organizations in China: a qualitative multiple case study. J 
Transl Med 2013;11:256.
 15 González- Alcaide G, Park J, Huamaní C, et al. Dominance and 
leadership in research activities: collaboration between countries of 
differing human development is reflected through authorship order 
and designation as corresponding authors in scientific publications. 
PLoS One 2017;12:e0182513.
 16 Rezaie R, McGahan AM, Frew SE, et al. Emergence of 
biopharmaceutical innovators in China, India, Brazil, and South 
Africa as global competitors and collaborators. Health Res Policy 
Syst 2012;10:18.
 17 Pham VNH, Hoang TM, Postma MJ. Pharmacoeconomic research 
and application in 10 Asian countries between 2003 and 2013: a 
systematic review. Value Health 2014;17:A793.
 18 Liu P, Mu X, Xie H. China’s scientific footprint in the global HIV/
AIDS research: Productivity, impact and collaboration. MJLIS 
2016;21:83–108.
 19 Sweileh WM, AbuTaha AS, Sawalha AF, et al. Bibliometric analysis 
of worldwide publications on multi-, extensively, and totally drug 
– resistant tuberculosis (2006–2015). Multidiscip Respir Med 
2017;11:1–16.
 20 Bai J, Li W, Huang Y- M, et al. Bibliometric study of research and 
development for neglected diseases in the BRICS. Infect Dis Poverty 
2016;5:89.
 21 Chen J, Bergquist R, Zhou X- N, et al. Combating infectious disease 
epidemics through China's belt and road initiative. PLoS Negl Trop 
Dis 2019;13:e0007107.
 22 Fan H- J, Gao H- W, Ding H, et al. The Ebola threat: China's 
response to the West African epidemic and national development 
of prevention and control policies and infrastructure. Disaster Med 
Public Health Prep 2015;9:64–5.
 23 Acharya A. Can Asia lead? power ambitions and global governance 
in the twenty- first century. Int Aff 2011;87:851–69.
 24 Ladle RJ, Todd PA, Malhado ACM. Assessing insularity in global 
science. Scientometrics 2012;93:745–50.
 25 Koplan JP, Bond TC, Merson MH, et al. Towards a common 
definition of global health. Lancet 2009;373:1993–5.
 26 World Bank. World bank country and lending groups, 2018. 
Available: https:// datahelpdesk. worldbank. org/ knowledgebase/ 
articles/ 906519- world- bank- country- and- lending- groups [Accessed 
Oct 15 2018].
 27 Hsieh H- F, Shannon SE. Three approaches to qualitative content 
analysis. Qual Health Res 2005;15:1277–88.
 28 Li M, Wei L, Liu H, et al. Integrative review of international nursing 
research in mainland China. Int Nurs Rev 2009;56:28–33.
 29 Wang Y- P, Zhou X- N. The year 2020, a milestone in breaking the 
vicious cycle of poverty and illness in China. Infect Dis Poverty 
2020;9:11.
 30 Xinhua. China, US to work together to help build African CDC, 2015. 
Available: https://www. chinadaily. com. cn/ world/ 7thcused/ 2015- 06/ 
25/ content_ 21103310. htm [Accessed 3 Jun 2020].
 31 Li A. Chinese medical cooperation in Africa : With special emphasis 
on the medical teams and anti- malaria campaign. Uppsala: Nordiska 
Afrikainstitutet ; Peking University, School of International Studies, 
2011.
 32 Phiri C. PRESS RELEASE: Chinese Nationals Murdered In Lusaka’s 
Makeni Area, 2020. Available: https:// zambiareports. com/ 2020/ 05/ 
25/ press- release- chinese- nationals- murdered- lusakas- makeni- area/ 
[Accessed 2 Jun 2020].
 33 Zhang P, Rui G. Coronavirus: crackdowns, racism and forced 
quarantine heighten tension for Africans in Guangzhou. South China 
Morning Post. 2020 May 2nd, 2020.
 34 Abimbola S, Pai M. Will global health survive its decolonisation? 
Lancet 2020;396:1627–8.
 35 Information Office of the State Council TPsRoC. China’s White Paper 
on Foreidn Aid, 2014.
 36 Liu PL, Berhane Y, Fawzi W, et al. China, Africa, and US academia 
join hands to advance global health. Lancet 2017;390:733–4.
